BioSpace News Archive

Press Releases

REPROCELL USA Receives Funding from the Maryland Stem Cell Research Fund (MSCRF)

October 23, 2025
·
3 min read
Press Releases

ADARx Pharmaceuticals Announces First Patient Dosed in Phase 3 STOP-HAE Clinical Trial and Orphan Drug Designation for ADX-324, a Long-Acting siRNA in Development for the Prophylactic Treatment of Hereditary Angioedema (HAE)

October 23, 2025
·
3 min read
Press Releases

Calidi Biotherapeutics Announces Establishment of Scientific Advisory Board to Support Development of CLD-401 and Advance its RedTail Platform for the Systemic Delivery of Targeted Genetic Medicine

October 23, 2025
·
9 min read
Press Releases

Fulcrum Therapeutics to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Wednesday, October 29, 2025, at 8:00 a.m. ET

October 23, 2025
·
1 min read
Press Releases

Vivani Medical to Present at the ThinkEquity Conference on October 30, 2025

October 23, 2025
·
4 min read
Press Releases

Data from REZOLVE-AD Phase 2b Study for Rezpegaldesleukin Accepted for Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting

October 23, 2025
·
8 min read
Press Releases

Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences

October 23, 2025
·
9 min read
Press Releases

Sironax Announces Key Leadership Appointments to Advance Global Drug Discovery and Development

October 23, 2025
·
4 min read
Press Releases

Astellas Presents Preliminary Real-World VEOZAH™ (fezolinetant) Data From OPTION-VMS Phase IV Observational Study

October 23, 2025
·
10 min read
Press Releases

In Treating Measles Infection, NV-387 Showed Strong Antiviral Activity, and Significantly, Protected Lungs from Damage, Describes NanoViricides

October 23, 2025
·
9 min read